Comparative Study of "Levobupivacaine with Dexmedetomidine" vs "Levobupivacaine with Buprenorphine" in Ultrasound-Guided Supraclavicular Brachial Plexus Block for Below-Elbow Orthopaedic Surgeries
International Journal of Drug Delivery Technology · 08.06.2026 · 16 (48s)
DOI: 10.25258/ijddt.16.48s.52 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von Sarvesh B und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Ultrasound-guided supraclavicular brachial plexus block is widely used for below-elbow orthopedic surgeries because it provides effective intraoperative anesthesia and prolonged postoperative analgesia. Various pharmacological adjuvants have been used with local anesthetics to improve block characteristics and extend analgesic duration. Dexmedetomidine, an α₂-adrenergic agonist, and buprenorphine, a partial μ-opioid agonist, are commonly used adjuvants in peripheral nerve blocks.
Aim
To compare dexmedetomidine and buprenorphine as adjuvants to levobupivacaine in ultrasound-guided supraclavicular brachial plexus block with respect to onset and duration of sensory and motor blockade, duration of postoperative analgesia, and adverse effects.
Methods
This prospective randomized double-blind study included 60 patients aged 18–60 years belonging to ASA physical status I–II undergoing elective below-elbow orthopedic surgeries. Patients were randomly allocated into two groups of 30 each. Group D received 19 mL of 0.5% levobupivacaine with dexmedetomidine 1 µg/kg diluted to 1 mL. Group B received 19 mL of 0.5% levobupivacaine with buprenorphine 3 µg/kg diluted to 1 mL. Primary outcomes included onset and duration of sensory and motor blockade and duration of postoperative analgesia. Secondary outcomes included hemodynamic changes, sedation scores, and adverse effects.
Results
Dexmedetomidine significantly reduced the onset time of sensory blockade (8.3 min vs 9.6 min; p = 0.004) and motor blockade (9.2 min vs 12.1 min; p < 0.001) compared with buprenorphine. Duration of sensory blockade (615 min vs 470 min), motor blockade (560 min vs 420 min), and duration of analgesia (720 min vs 580 min) were significantly prolonged in the dexmedetomidine group. Bradycardia was observed in two patients in the dexmedetomidine group, whereas nausea and vomiting occurred in four patients in the buprenorphine group.
Conclusion
Dexmedetomidine as an adjuvant to levobupivacaine in ultrasound-guided supraclavicular brachial plexus block provides faster onset of blockade, prolonged postoperative analgesia, and fewer opioid-related adverse effects compared with buprenorphine.
Zitieren
APA
B, S., Krishnan, U. A., & Yesudas, A. (2026). Comparative Study of "Levobupivacaine with Dexmedetomidine" vs "Levobupivacaine with Buprenorphine" in Ultrasound-Guided Supraclavicular Brachial Plexus Block for Below-Elbow Orthopaedic Surgeries. International Journal of Drug Delivery Technology, 16(48s). https://doi.org/10.25258/ijddt.16.48s.52
Vancouver
B S, Krishnan UA, Yesudas A. Comparative Study of "Levobupivacaine with Dexmedetomidine" vs "Levobupivacaine with Buprenorphine" in Ultrasound-Guided Supraclavicular Brachial Plexus Block for Below-Elbow Orthopaedic Surgeries. International Journal of Drug Delivery Technology. 2026;16(48s). doi:10.25258/ijddt.16.48s.52
BibTeX
@article{B2026,
author = {B, Sarvesh and Krishnan, U Anand and Yesudas, Abhishek},
title = {Comparative Study of "Levobupivacaine with Dexmedetomidine" vs "Levobupivacaine with Buprenorphine" in Ultrasound-Guided Supraclavicular Brachial Plexus Block for Below-Elbow Orthopaedic Surgeries},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {48s},
doi = {10.25258/ijddt.16.48s.52}
}
EUVIMED